Pharmaceutical

Muna-GSK alliance to fast-track Alzheimer’s disease treatments

Muna has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and validating new drug targets.

Dec 7, 2024 - 06:00
Muna-GSK alliance to fast-track Alzheimer’s disease treatments
Muna has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and validating new drug targets.
Read the original article

Tags:

Previous Article

Centenarians – unlocking the secrets of living to 100

Next Article

FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BioVersys and GSK expand their partnership for TB treatment alpibectir

BioVersys and GSK expand their partnership for TB treat...

May 9, 2024

Opinion: Why brain decoding is not mind reading — and why that matters

Opinion: Why brain decoding is not mind reading — and w...

Jun 8, 2023

Glenmark to market Winlevi in Europe and South Africa after Cosmo deal

Glenmark to market Winlevi in Europe and South Africa a...

Sep 27, 2023